Fluoroquinolone-Associated Myasthenia Gravis Exacerbation

@article{Jones2011FluoroquinoloneAssociatedMG,
  title={Fluoroquinolone-Associated Myasthenia Gravis Exacerbation},
  author={S. Christopher Jones and Alfred Sorbello and Robert M Boucher},
  journal={Drug Safety},
  year={2011},
  volume={34},
  pages={839-847}
}
AbstractBackground: Exacerbations of myasthenia gravis have been reported in antibacterial-treated patients. In animal and in vitro models of experimentallyinduced myasthenia gravis, fluoroquinolones exhibit neuromuscular blockade. Objective: The aim of this retrospective study was to evaluate postmarketing adverse event reports submitted to the US FDA and case reports published in the scientific literature for a potential association between fluoroquinolone exposure and acute exacerbations of… Expand
Exacerbation of myasthenia gravis after amoxicillin therapy: a case series
TLDR
It is concluded that patients receiving amoxicillin should be closely monitored for possible acute relapse. Expand
Safety and Tolerability of Moxifloxacin in Children
TLDR
AEs that occur during pediatric moxifloxacin therapy are relatively common but rarely serious enough to require premature discontinuation and the drug might be used safely in most children with monitoring, including evaluation for QTc prolongation, and guidance from ID specialists. Expand
Myasthenia gravis and infectious disease
TLDR
This is a review article, where Web of Science has been searched for relevant key words and key word combinations to find papers with relevance for the risk of infections as well as their prophylactic and curative treatment. Expand
Daptomycin Use in MRSA Bacteremia of a Patient with Myasthenia Gravis: A Case Report -
TLDR
The experience about daptomycin use in Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia of a patient with myasthenia gravis is shared. Expand
Emergency Department Management of a Myasthenia Gravis Patient with Community-Acquired Pneumonia: Does Initial Antibiotic Choice Lead to Cure or Crisis?
TLDR
This patient case highlights the addition of tigecycline to the armamentarium of therapies available to treat myasthenia gravis patients presenting to the emergency department with CAP. Expand
Management of myasthenia gravis in daily practice for general neurologists and healthcare professionals
TLDR
The present review aims to improve the understanding of current MG diagnosis, specific immunotherapy and clinical management tips, not only for the general neurologist, but also for other medical staff. Expand
Adverse Effects of Fluoroquinolones: A Retrospective Cohort Study in a South Indian Tertiary Healthcare Facility
TLDR
A harmful association between FQ use and the development of ADRs is concluded, and FQs are not safe compared to other antibiotics, Hence, the use of F Qs should be limited to the conditions where no other alternatives are available. Expand
Ocular Myasthenia Induced by Rivaroxaban in Patient with Deep Vein Thrombosis.
TLDR
This report of ocular myasthenia by rivaroxaban administration is the first in the literature and it is important to recognize unexpected immune-related adverse events. Expand
Myasthenia Gravis and Crisis: Evaluation and Management in the Emergency Department.
TLDR
Emergency department management of myasthenia gravis should focus on ruling out infection and respiratory support, and Corticosteroids, depolarizing paralytics, and acetylcholinesterase inhibitors should be avoided in patients with MC in the emergency department. Expand
An update on myasthenia gravis, challenging disease for the dental profession.
TLDR
Oral manifestations, treatment timing and modality, the choice and effects of drugs and medications, and prevention of myasthenic crisis are all important aspects with which dentists and oral health care providers should be thoroughly acquainted. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 21 REFERENCES
Exacerbation of Myasthenia Gravis by Norfloxacin
TLDR
The two antibiotics proved to be comparable when used in the prophylaxis of clean-contaminated surgery and in the treatment of infection due to susceptible organisms and the longer half-life allows for a twice-daily dosing regimen and a single preoperative dose for surgical prophYLaxis. Expand
[Exacerbation of myasthenia gravis by pefloxacin].
TLDR
Ciprofloxacine 800 mg single dose was given as routine treatment after a cystomanometric examination to a 45-year-old woman with a 30-month history of generalized myasthenia gravis, and the report of exacerbation of myASThenia Gravis with other antibiotic belonging to the group of fluoroquinolones prompt caution with the use of all fluoroquolones in myastshenic patients. Expand
Ciprofloxacin and myasthenia gravis.
TLDR
This work reports on three patients with cryptococcal meningitis in whom clinical relapse seemed to be associated with concurrent administration of fluconazole and rifampicin, and suggests that these cases provide some clinical support for the observation that rifampsicin interferes with the pharmacokinetics of flu Conazole. Expand
Drug‐Induced Neuromuscular Blockade and Myasthenia Gravis
TLDR
Drugs most likely to impact myasthenic patients negatively are those used in the treatment of the disease, including overuse of anticholinesterase drugs, high‐dose prednisone, and anesthesia and neuromuscular blockers for thymectomy. Expand
Ofloxacin in the Lambert-Eaton myasthenic syndrome.
TLDR
The study caps several case reports in which symptoms of MG worsen following the use of fluoroquinolones, and presents a similar danger in the Lambert-Eaton myasthenic syndrome (LEMS). Expand
SEROPOSITIVE MYASTHENIA GRAVIS: A NATIONWIDE EPIDEMIOLOGIC STUDY
TLDR
The aims of this study were to determine the incidence and prevalence of AChR antibody-positive (seropositive) MG, to describe its gender-specific characteristics, and to examine epidemiologic trends during the last decades. Expand
Probable exacerbation of myasthenia gravis by ofloxacin
1. Arendt G, Hefter H, Elsing C, Strohmeyer G, Freund HJ (1990) Motor dysfunction in HIV-infected patients without clinically detectable central nervous deficit. J Neurol 237 : 362-368 2. DeGans J,Expand
The Incidence of Myasthenia Gravis: A Systematic Literature Review
TLDR
Overall, incidence rates have increased over time owing to a greater awareness of the disease and improved methods of diagnosis, and it is thought that the rates at the upper end of this range, reported by the prospective studies, provided the most accurate estimates. Expand
Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction.
TLDR
The time course of the clinical and electrophysiologic findings during provocation with chloroquine and the absence of autoantibodies indicate that the syndrome was due to a direct effect of the drug on the neuromuscular junction, which can explain the apparent rarity of the syndrome described. Expand
Prulifloxacin as a trigger of myasthenia gravis
TLDR
A case of myasthenia gravis is presented following a treatment with prulifloxacin, a new broad-spectrum oral fluoroquinolone, which should be avoided in patients with MG. Expand
...
1
2
3
...